Merck & Co. Inc. buy UBS Group AG
Start price
20.10.23
/
50%
€94.60
Target price
20.10.24
€115.24
Performance (%)
5.92%
End price
21.10.24
€100.20
Summary
This prediction ended on 21.10.24 with a price of €100.20. With a performance of 5.92%, the BUY prediction by UBS_Group_AG for Merck & Co. Inc. closed with a slight gain. UBS_Group_AG has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.82 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 1.198% | 1.198% | -11.518% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by UBS_Group_AG for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $122.00 price target on the stock, up previously from $117.00.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Merck & Co. Inc.
Stopped prediction by UBS_Group_AG for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.36
31.07.25
31.07.25
-34.80%
01.08.25
01.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€117.60
02.02.24
02.02.24
€137.06
02.02.25
02.02.25
-18.88%
03.02.25
03.02.25